Helena Cabral Marques is an Associate Professor (with Habilitation) of Pharmaceutical Technology in Faculty of Pharmacy, University of Lisbon. She has been a Fellow of the Alexander von Humboldt Foundation since 1997 and is also a Member of the Commission of the Portuguese Pharmacopoeia (Government nomination, since 1997), INFARMED. Her research team is focused on the development of cyclodextrin-based systems for pulmonary, transdermal, ophthalmic and oral delivery of bioactive molecules. Presently, she is focused on the drug specific construction of cyclodextrin nanosystems able to modulate the desired physicochemical and pharmacokinetic profiles of loaded drug molecules in order to achieve its translocation across biological membranes for targeted delivery and pharmacologic activity. She is also exploiting the cell membrane disrupting potential of cyclodextrin molecules for the construction of drug delivery polymers able to elicit synergistic therapeutics effects. Another area of interest is the use of pharmaceutical processing technologies such as Supercritical fluids technology and 3-D printing for the preparation of cyclodextrin based drug delivery systems. She has published more than 100 research papers, book chapters and conference proceedings. She has an h-index of 26 (Google Scholar) and has been cited more than 2200 times.